The Role of Choice in Weight Loss Strategies: A Systematic Review and Meta-Analysis

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
obesity 6 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
obesity 2142 strategy did not confer a weight loss benefit.1. IntroductionAs the worldwide prevalence of overweight and obesity increases with 39% of the worlds’ adult population overweight (BMI 25–29.9kg/m2) and 13% obese (BMI
obesity 7145 weight loss.tw OR choice and diet* prefer*.tw OR choice and weight loss.tw OR treatment prefer* and obesity .tw OR diet* prefer* and weight loss.tw OR diet* prefer* and weight management.tw OR diet* prefer* and
obesity 23490 a strong preference for the CSIRO diet. While current global statistics suggest that overweight and obesity in men is increasing [[1]], overallan average male participation in weight loss trials has been estimated
obesity 23629 overallan average male participation in weight loss trials has been estimated at 27% [[48]]. With male obesity rising more rapidly than female figures in high-income countries [[49]], the underrepresentation of
obesity 31362 Baseline data was collected during week 1 and again at 3 months.≥18 yearsBMI ≥ 30 kg/m2 with no obesity related comorbidities or ≥25 kg/m2 if South AsianBMI ≥ 28 kg/m2 with obesity related comorbidities
obesity 31443 ≥ 30 kg/m2 with no obesity related comorbidities or ≥25 kg/m2 if South AsianBMI ≥ 28 kg/m2 with obesity related comorbidities or≥23 kg/m2 if South Asian.740658(11.1%)Participants were randomized to; Weight

You must be authorized to submit a review.